These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15991018)
1. A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention. Shields AF; Briston DA; Chandupatla S; Douglas KA; Lawhorn-Crews J; Collins JM; Mangner TJ; Heilbrun LK; Muzik O Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1269-75. PubMed ID: 15991018 [TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. Muzi M; Vesselle H; Grierson JR; Mankoff DA; Schmidt RA; Peterson L; Wells JM; Krohn KA J Nucl Med; 2005 Feb; 46(2):274-82. PubMed ID: 15695787 [TBL] [Abstract][Full Text] [Related]
3. Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. Muzi M; Mankoff DA; Grierson JR; Wells JM; Vesselle H; Krohn KA J Nucl Med; 2005 Feb; 46(2):371-80. PubMed ID: 15695799 [TBL] [Abstract][Full Text] [Related]
4. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896 [TBL] [Abstract][Full Text] [Related]
6. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer. Visvikis D; Francis D; Mulligan R; Costa DC; Croasdale I; Luthra SK; Taylor I; Ell PJ Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):169-78. PubMed ID: 15129698 [TBL] [Abstract][Full Text] [Related]
8. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196 [TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy. Menda Y; Boles Ponto LL; Dornfeld KJ; Tewson TJ; Watkins GL; Schultz MK; Sunderland JJ; Graham MM; Buatti JM J Nucl Med; 2009 Jul; 50(7):1028-35. PubMed ID: 19525472 [TBL] [Abstract][Full Text] [Related]
10. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Kenny LM; Vigushin DM; Al-Nahhas A; Osman S; Luthra SK; Shousha S; Coombes RC; Aboagye EO Cancer Res; 2005 Nov; 65(21):10104-12. PubMed ID: 16267037 [TBL] [Abstract][Full Text] [Related]
11. Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer. Shields AF; Lawhorn-Crews JM; Briston DA; Zalzala S; Gadgeel S; Douglas KA; Mangner TJ; Heilbrun LK; Muzik O Clin Cancer Res; 2008 Jul; 14(14):4463-8. PubMed ID: 18628460 [TBL] [Abstract][Full Text] [Related]
12. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975 [TBL] [Abstract][Full Text] [Related]
13. The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. Barthel H; Perumal M; Latigo J; He Q; Brady F; Luthra SK; Price PM; Aboagye EO Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):257-63. PubMed ID: 15791434 [TBL] [Abstract][Full Text] [Related]